Last reviewed · How we verify
Ketoprofen in Transfersome
Inhibits COX-2
Inhibits COX-2 Used for Pain relief, Inflammation.
At a glance
| Generic name | Ketoprofen in Transfersome |
|---|---|
| Sponsor | IDEA AG |
| Drug class | NSAID |
| Target | COX-2 |
| Modality | Small molecule |
| Therapeutic area | Pain Management |
| Phase | Phase 2 |
Mechanism of action
Ketoprofen is a nonsteroidal anti-inflammatory drug (NSAID) that selectively inhibits cyclooxygenase-2 (COX-2), an enzyme involved in the production of prostaglandins, which mediate inflammation and pain.
Approved indications
- Pain relief
- Inflammation
Common side effects
- Gastrointestinal upset
- Dizziness
- Headache
Key clinical trials
- Study of Epicutaneously Applied Ketoprofen Transfersome® Gel With or Without Combination With Oral Celecoxib for the Treatment of Muscle Pain Induced by Eccentric Exercise (PHASE1)
- Safety and Efficacy of Two Dosages of Diractin® in Osteoarthritis (OA) (PHASE3)
- Study of Safety and Efficacy of Diractin® for the Treatment of Osteoarthritis (OA) of the Knee (PHASE3)
- Ketoprofen in Transfersome Compared to Oral Celecoxib and Placebo for Pain Associated With Osteoarthritis of the Knee (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ketoprofen in Transfersome CI brief — competitive landscape report
- Ketoprofen in Transfersome updates RSS · CI watch RSS
- IDEA AG portfolio CI